Literature DB >> 19997058

The independent association between serum uric acid and graft outcomes after kidney transplantation.

Abdolreza Haririan1, Joseph M Nogueira, Joseph M Noguiera, Kambiz Zandi-Nejad, Ravi Aiyer, Heather Hurley, Matthew Cooper, David K Klassen, Matthew R Weir.   

Abstract

BACKGROUND: Improving long-term outcomes of kidney transplantation depends on identifying novel risk factors that lead to poor outcomes. We sought to evaluate the predictive value of mean uric acid (UA) level during the first 6 months posttransplant for graft survival and function.
METHODS: Two hundred twelve recipients of living donor kidneys transplanted during January 2000 to December 2001 were included. The study outcome included graft and patient survival and graft function at 1 year posttransplant. Regression models were used to adjust for the confounding variables including graft function during first 6 months.
RESULTS: During 68.3 + or - 27.2 months follow-up, UA level (mg/dL) and hyperuricemia (n=45) were associated with graft loss (hazard ratio [HR]=1.26, P=0.026, 95% confidence interval [CI]=1.03-1.53, and HR=1.92, P=0.029, 95% CI=1.1-3.4, respectively) independent of graft function and other confounders. UA also seemed to be associated with risk of death with borderline significance (HR=1.2, P=0.096, 95% CI=0.97-1.46). Examining the predictive value for graft function, UA level and hyperuricemia were independent predictors of 1-year serum creatinine (beta=0.10, P=0.013, 95% CI=0.02-0.18, and beta=0.25, P<0.04, 95% CI=0.01-0.49, respectively). Similarly, both were associated with 1-year estimated glomerular filtration rate (beta=-3.9, P<0.001, 95% CI=-5.7 to -1.5 for UA, and beta=-7.6, P<0.02, 95% CI=-13.6 to -1.5 for hyperuricemia). Notably, these associations were all independent of renal function during first 6 months.
CONCLUSION: The results of this study suggest that mean UA level during the first 6 months posttransplant is an independent predictor of long-term graft survival and short-term graft function. Further investigations are needed to evaluate its causal association with chronic allograft injury and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19997058     DOI: 10.1097/TP.0b013e3181c73c18

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  20 in total

Review 1.  Urate reduction and renal preservation: what is the evidence?

Authors:  Nicolas Macías; Marian Goicoechea; M S García de Vinuesa; Ursula Verdalles; Jose Luño
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

2.  Uric acid and chronic kidney disease: A time to act?

Authors:  Gianni Bellomo
Journal:  World J Nephrol       Date:  2013-05-06

Review 3.  Uric acid as a target of therapy in CKD.

Authors:  Diana I Jalal; Michel Chonchol; Wei Chen; Giovanni Targher
Journal:  Am J Kidney Dis       Date:  2012-10-09       Impact factor: 8.860

4.  Asymptomatic hyperuricemia following renal transplantation.

Authors:  Gianni Bellomo
Journal:  World J Nephrol       Date:  2015-07-06

Review 5.  Allopurinol, uric acid, and oxidative stress in cardiorenal disease.

Authors:  Markus Riegersperger; Adrian Covic; David Goldsmith
Journal:  Int Urol Nephrol       Date:  2011-03-10       Impact factor: 2.370

Review 6.  Challenges of conducting a trial of uric-acid-lowering therapy in CKD.

Authors:  Sunil V Badve; Fiona Brown; Carmel M Hawley; David W Johnson; John Kanellis; Gopala K Rangan; Vlado Perkovic
Journal:  Nat Rev Nephrol       Date:  2011-02-15       Impact factor: 28.314

7.  The effects of mammalian target of rapamycin inhibitors on serum uric acid levels in renal transplant patients.

Authors:  Ozkan Gungor; Mehmet Tanrisev; Fatih Kircelli; Mehmet Nuri Turan; Cem Tugmen; Erhan Tatar; Huseyin Toz
Journal:  Int Urol Nephrol       Date:  2012-06-30       Impact factor: 2.370

8.  Serum uric acid levels and long-term outcomes in chronic kidney disease.

Authors:  Tokiko Miyaoka; Toshio Mochizuki; Takashi Takei; Ken Tsuchiya; Kosaku Nitta
Journal:  Heart Vessels       Date:  2013-08-09       Impact factor: 2.037

9.  Hyperuricemia beyond 1 year after kidney transplantation in pediatric patients: Prevalence and risk factors.

Authors:  B Einollahi; H Einollahi; Z Rostami
Journal:  Indian J Nephrol       Date:  2012-07

10.  Prevalence and risk factors of hyperuricemia among kidney transplant recipients.

Authors:  B Einollahi; H Einollahi; M Nafar; Z Rostami
Journal:  Indian J Nephrol       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.